Acutus Medical rises as heart device shows promise in study

Acutus Medical

06/02/2023 13:41

** Shares of medical device maker Acutus Medical Inc
 AFIB.O  rise ~4% to $1.86 premarket
    ** Company says heart device study achieved success in 94%
of patients with no serious adverse effects, where ablation time
was 33% less vs comparative systems 
    ** Study enrolled 110 patients at 21 sites globally and was
designed to evaluate safety and efficacy of AcQBlate FORCE
sensing ablation catheter and system for treatment of right
atrial typical flutter
    ** Cardiac ablation is a procedure that scars tissues in the
heart to correct heart rhythm problems
    ** Acutus submitted its premarket approval application for
the device on Oct. 3, 2022 and it is currently under review
    ** Company's shares fell ~66% in 2022
 (Reporting by Sriparna Roy)
 ((Sriparna.Roy@thomsonreuters.com))